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Abstract
Background: Dietary quercetin improves cardiovascular health, relaxes some vascular smooth muscle and has been
demonstrated to serve as a substrate for the cyclooxygenase enzyme.
Aims: 1. To test quantitatively a potential direct vasodilatory effect on intramural coronary resistance artery segments, in
different concentrations. 2. To scale vasorelaxation at different intraluminal pressure loads on such vessels of different size.
3. To test the potential role of prostanoids in vasodilatation induced by quercetin.
Methods: Coronary arterioles (70–240 mm) were prepared from 24 rats and pressurized in PSS, using a pressure
microangiometer.
Results: The spontaneous tone that developed at 50 mmHg was relaxed by quercetin in the 1029 moles/lit concentration
(p,0.05), while 1025 moles/lit caused full relaxation. Significant relaxation was observed at all pressure levels (10–
100 mmHg) at 1027 moles/lit concentration of quercetin. The cyclooxygenase blocker indomethacin (1025moles/lit)
induced no relaxation but contraction when physiological concentrations of quercetin were present in the tissue bath (p,
0.02 with Anova), this contraction being more prominent in smaller vessels and in the higher pressure range (p,0.05,
Pearson correlation). A further 2–8% contraction could be elicited by the NO blocker L-NAME (1024 moles/lit).
Conclusion: These results demonstrate that circulating levels of quercetin (1027 moles/lit) exhibit a substantial coronary
vasodilatory effect. The extent of it is commeasurable with that of several other physiological mechanisms of coronary
blood flow control. At least part of this relaxation is the result of an altered balance toward the production of endogenous
vasodilatory prostanoids in the coronary arteriole wall.
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Introduction
Dietary polyphenols, with quercetin being a member of this
group, are present in substantial amount in various vegetables,
fruits, vine and tea, and have beneficial effects on the vessel wall
[1–3]. They delay atherosclerotic processes [4] and reduce
hypertension [1,5–7]. Quercetin and rutin components of food
are easily absorbed, and rutin is transformed into quercetin [8]. Its
glucuronide and sulfate conjugates appear in blood plasma [9–11].
These metabolites are cleaved in the peripheral tissues in situ,
vessel wall included [12]. A vasorelaxation effect was described
both in vivo and in vitro experiments [13–15]. While tissue blood
flow is controlled dominantly by resistance arteries, quercetin
effects have been studied mainly on larger vessels. Both
endothelium dependent [16] and independent [17] mechanisms
of quercetin-induced vasorelaxation have been described. They
can be different in different vascular fields. Quercetin was found to
be a reducing co-substrate of the second step in the cyclooxygenase
(COX) enzymatic reaction [18], thus affecting endogenous
prostanoid production [19].
Intramural coronary resistance arteries have a marked sponta-
neous myogenic tone which is substantially modified by endothe-
lial relaxation and endogenous prostanoid production. Both
vasoconstrictor and vasodilator prostanoids are produced by
intramural coronary resistance arteries, vasoconstrictors prevailing
at higher intraluminal pressures [20].
One of the aims of the present study was to test quantitatively if
coronary resistance arteries do show a direct vasodilation in
response to physiological concentrations of quercetin. In addition,
we investigated the quercetin effect on coronary arterioles of
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different sizes at intact, cylindrical vascular geometry, as according
to earlier observations, pharmacological modulation of smaller
and larger resistance arteries may differ substantially [21]. After
we have found a significant dilation effect, it was assumed that this
action could be initiated at least partly through altered production
of endogenous vasoactive prostanoids. This hypothesis was tested
by indomethacin inhibition of COX activity in vessel segments of
different caliber and at different intraluminal pressures.
Materials and Methods
Pressure microangiometry
Male Wistar rats, weighing 350–450 gr were anesthetized by
pentobarbital (Nembutal, CEVA, 45 mg/kg body weight i.p.). All
procedures conformed the Guide for the Care and Use of
Laboratory Animals (NIH, 1996), the legal and institutional
guidelines for animal care and were approved by the Animal Care
Committee of the Semmelweis University.
The heart was removed and put in cold oxygenized physiolog-
ical salt solution (PSS). A terminal branch of the left anterior
descendent coronary artery (intramural small artery in the rat) was
prepared from the ventricular muscle tissue. Vessel segments with
no or with limited number of side branches, having outer diameter
of 150–250 mm in situ were selected. Preparation was made as
described earlier [22]. Excised segments, with lengths over 2.0 mm
were cannulated at both ends using microcannulas (outer diameter
,130 mm) and mounted in a glass bottomed tissue bath. Their
length was extended to the original in situ value. Segments were
pressurized with saline connecting them to servo-controlled pumps
(Living Systems, Burlington, VT, US). The temperature of the
Figure 1. Concentration-response curve of quercetin on coronary resistance arterioles of rat. Intramural coronary arteriole segments
were spontaneously contracted, then dilatated by quercetin at intraluminal pressure 50 mmHg. (PSS, Krebs-Ringer solution, Ca2+-free, Ca2+-free
solution). #, significantly different from fully relaxed; ¤, different from spontaneously contracted with ANOVA; * different from spontaneously
contracted with the paired t-test.
doi:10.1371/journal.pone.0105587.g001
Figure 2. Quercetin dilation on spontaneously contracted small coronary arterioles at different pressures. Full circles represents
diameters in PSS, empty circles are diameters in quercetin 1027 moles/lit. * p,0.05 with ANOVA
doi:10.1371/journal.pone.0105587.g002
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bath was thermostated at 37uC, and bubbled with a gas mixture of
5% CO2, 20% O2 and 75% of N2, keeping pH at 7.4. A
continuous superfusion velocity of 2.8 ml/min was ensured. The
bath was positioned on the stage of an inverted microscope (Leica),
the pictures of the segments were taken by a digital camera (Leica
DFC 320) and an image analyzing software (Leica Qwin). Outer
and inner diameters of segments were measured off-line on frozen
pictures. Calibration was made using a micrometer etalon (Wild).
Materials
All drugs, including quercetin, were purchased from Sigma-
Aldrich. The composition of the PSS (Krebs-Ringer solution) we
used: NaCl 119, KCl 4.7, NaH2PO4 1.2, MgSO4 1.17, NaHCO3
24, CaCl2 2.5, glucose 5.5, and EDTA 0.034 (in mmol/lit). The
Ca2+-free PSS contained: NaCl 92, KCl 4.7, NaH2PO4 1.18,
MgCl2 20, MgSO4 1.17, NaHCO3 24, glucose 5.5, EGTA 2, and
EDTA 0.025 (in mmol/lit).
In vitro protocols
In the first series of experiments, concentration-response curves
with quercetin were taken on coronary resistance artery segments
from 8 rats. To do that, segments were pressurized at 50 mmHg.
This pressure was continuously kept throughout the measurement.
Such segments develop substantial spontaneous tone under similar
circumstances. After 40 minutes of equilibration, superfusion was
changed to PSS containing increasing concentrations of quercetin
from 1029 to 1025 moles/lit. (Physiological concentrations in
humans are reported to be 1027 moles/lit [7].) 20 min equilibra-
tion was left for all steps, at the end of which stable diameters were
registered. Reversibility was checked by repeated administration of
Figure 3. Quercetin induced dilatation as function of morphological lumen size. We found no correlation (p.0.05 with Pearson’s
correlation).
doi:10.1371/journal.pone.0105587.g003
Figure 4. Effect of indomethacin on inner diameter of quercetin-treated coronary arteriole segments. Note contraction with
indomethacin (p,0.05 with ANOVA), in contrast the expected vasodilation, indicating the presence of vasodilatory prostanoids with the polyphenol.
Indomethacin concentration was 1025 moles/lit, represented by full circles, quercetin was in 1027 moles/lit concentration, represented by empty
circles.
doi:10.1371/journal.pone.0105587.g004
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PSS. Finally, calcium-free PSS was superfused (20 minutes) and
relaxed diameters were measured. Concentration-response curves
were determined. Relaxation from spontaneous tone was ex-
pressed in percents of fully relaxed diameter.
In a second series, pressure-radius curves were taken using 16
similar vessel segments. Pressure was raised in 10 mmHg steps
from 10 up to 100 mmHg. Then 1027 mol/lit quercetin
containing PSS solution was superfused, and the pressure-radius
curves were repeatedly taken. Next, the cyclooxygenase blocker
indomethacin was applied (1025 moles/lit) with the quercetin still
in the bath. NO effect was tested by additional application of the
NO blocker L-NAME (1024 moles/lit). Reproducibility was
controlled by repeated measurements with 1027 moles/lit
quercetin alone and then with PSS without any drug added
(spontaneous tone). The experiment was terminated by superfu-
sion with Ca2+-free PSS (full relaxation). Contractions and
relaxations were expressed in % of inner diameter measured at
the same pressure in Ca2+-free PSS.
Statistical procedures
Values are expressed as means 6 SEM. Statistical analysis was
performed using paired t-test, or two-way repeated measures
ANOVA, followed by Tukey post-hoc test. Values of p,0.05 were
considered statistically significant.
Figure 5. Correlation of indomethacin induced contraction on quercetin-dilated segments with the morphological lumen size. Note
a more prominent contraction in smaller vessels (p,0.05 with Pearson’s correlation).
doi:10.1371/journal.pone.0105587.g005
Figure 6. Vasoconstriction induced by L-NAME in coronary arteriole segments pretreated with quercetin and indomethacin.
Concentrations: L-NAME: 1024 moles/lit, quercetin: 1027 moles/lit, and indomethacin: 1025 moles/lit. * p,0.05 with ANOVA
doi:10.1371/journal.pone.0105587.g006
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Results
In the first series, the vessel segments incubated in oxygenized
PSS exhibited a substantial spontaneous tone. At 50 mmHg
intravascular pressure, the average inner diameter was
127625 mm, which corresponds to a 20.264.3% contraction
from fully relaxed state. Increasing concentrations of quercetin
induced increasing relaxations. In 1029 moles/lit concentration,
statistically significant relaxation was seen, while 1025 moles/lit
fully relaxed the segments. This relaxation (reduction of sponta-
neous tone) was found to be reversible, as original tone returned
upon washing off the substance (Fig. 1.).
In the second series of experiments, 1027 mol/lit quercetin
concentration was further tested on pressure-radius curves in the
pressure range of 10–100 mmHg. A massive dilation was found at
all pressure levels studied (Fig. 2.). There was no significant
correlation between the extent of quercetin-dilation and the
morphological diameter of the segments (Fig. 3).
The COX blocker indomethacin, in a concentration of 1025
moles/lit induced a significant contraction of all quercetin treated
segments at all pressure levels (Fig. 4.). This effect seems to depend
on morphological lumen size: a statistically significant negative
correlation between morphological diameter (Ca2+-free solution,
100 mmHg pressure) and indomethacin induced contraction at
higher pressures (60–100 mmHg) was found (Fig. 5.).
Finally, the NO-blocker L-NAME was given (1024 moles/lit) to
test the level of endothelial vasodilation. Significant contraction
was found, but its extent varied only between 2–8% of relaxed
diameter (Fig. 6.).
Discussion
In this study it was proved that the polyphenol quercetin elicits a
direct concentration-dependent vasodilation on intramural coro-
nary resistance arteries at physiologically realistic concentrations.
In the very low concentration of 1029 moles/lit a slight but
significant relaxation was found in the intrinsic spontaneous tone.
Equivalent to the physiological concentration range of 1027
moles/lit in humans [7] resulted in 10.161.5% elevation in the
inner diameter. Close to the therapeutic concentrations of 1026
moles/lit quercetin [7], the spontaneous vascular tone almost fully
diminished. Quercetin, it proves, can be listed among potent
known coronary vasodilators. A direct vasodilatory action of
quercetin has been demonstrated until now exclusively on ring
preparations of larger vessels, on major coronary arteries [13–
17,23,24], as well as on resistance size mesenteric [17], and
coronary arteries [25]. The pressure microangiometry method we
applied was able to demonstrate vasodilatory actions of quercetin
at physiologically and pharmacologically realistic concentrations,
at real intraluminal pressures and inducing hemodynamically
substantial alterations in inner diameter.
In addition, we found, that relaxation caused by 1027 moles/lit
quercetin on the small coronary arterioles does not depend on
vessel diameter in the range of 70–250 mm, all samples relaxed by
appr.10 percents. It means that the spontaneous tone was reduced
to its half in each segment simply by the presence of physiological
concentrations of quercetin in the tissue bath. As smaller coronary
resistance arteries have larger tone, the vasorelaxation induced on
smaller vessels were more potent. Considering Hagen-Poiseuille’s
law, this might induce approximately 22–28% increase in flow at
larger arterioles (over 150 mm diameter), and 42–50% increase at
smaller coronaries (under 150 mm diameter).
Our measurements provide some further insight into the
possible mechanism of this vasodilatory action. Quercetin treated
coronary arteriole segments contracted at all transmural pressures
studied in response to the cyclooxygenase (COX) blocker
indomethacin, proving the presence and activity of vasodilatory
endogenous prostanoids in the vascular wall under the polyphenol
effect. According to earlier observations, without quercetin, similar
preparations produce mostly vasoconstrictor prostanoids when
challenged with increasing intraluminal pressures [26]. This points
to one potential mechanism of the vasodilation: altered balance
toward vasodilatory prostanoids in the coronary resistance artery
wall. As to the molecular mechanism, quercetin was reported to be
a modulator in the COX enzymatic reaction [19], in this way
affecting the endogenous prostanoid production [26,27]. Our
results are in good agreement with these observations. Pharma-
cological modulation of vasoactive endogenous prostanoid pro-
duction in the vessel wall has been demonstrated earlier with our
contribution [26,27].
Addition of the NO blocker L-NAME to the tissue bath induced
vasoconstriction, but its extent (2–8% at different pressures) does
not indicate a substantial NO-dependent vasorelaxing effect of
quercetin. Namely, it is not larger than the L-NAA induced
contractions of similar segments with indomethacin in the bath
without the presence of quercetin [26]. It is well-known that
quercetin exhibits antioxidant [28,29] and ROS scavenging
properties [30]. This can help to preserve NO, and provide
longer half-life time, to express vasodilatation [31].
In conclusion, these experiments suggest that physiological
circulating levels of quercetin continuously keep activated a
coronary vasodilatory system, of which significance and extent is
comparable with those of several other physiological mechanisms
of coronary resistance control. Our observations suggest that
production of endogenous vasodilatory prostanoids depends on
the presence of such reducing agents as the polyphenols. Here, we
can cite the original view of the Nobel-prize winner Hungarian
biochemist Albert Szentgyo¨rgyi, who suggested to recognize
dietary polyphenols as vitamins [32] (‘‘vitamin P’’ he called them).
This view was challenged later because of absence of manifest
deficiency symptoms [33]. We assume that the prevailing massive
metabolic control (hypoxic vasodilation) of cardiac tissue perfusion
easily overrides the missing polyphenol-relaxation, this way
masking deficiency symptoms. However, if under pathological
circumstances, the balance of vasoconstriction-relaxation is
disturbed, it might reduce remaining control capacity. Maintain-
ing a physiological quercetin concentration in the blood plasma
may help correct the balance toward vasorelaxation in coronary
arterioles.
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